Researchers used multiomics to chart tiny peptides encoded by small open reading frames in rice long noncoding RNAs. Plant biology, not medicine.
Recap by typeshit. Post by The Plant Cell on X.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Her point: food industry habits and sedentary lifestyles that drove weight gain are still there, even as millions start these medications.
Fallon says semaglutide and tirzepatide pull in about 60% of the combined run rate revenue of Anthropic and OpenAI, at a sixth of the reach.
Loading…